Angle (AGL)

Sector:

Support

Index:

FTSE AIM All-Share

8.25p
   
  • Change Today:
    -0.45p
  • 52 Week High: 31.35
  • 52 Week Low: 8.11
  • Currency: UK Pounds
  • Shares Issued: 322.64m
  • Volume: 1,956,110
  • Market Cap: £26.62m
  • RiskGrade: 312
  • Beta: 0.20

Regulatory News

Prostate Cancer UK funds new study using Parsortix 20-May-2022 07:00 RNS
Preliminary Results 28-Apr-2022 07:00 RNS
Notice of Preliminary Results and Webcast 20-Apr-2022 07:00 RNS
Poster on Parsortix system presented at AACR 2022 14-Apr-2022 07:00 RNS
Identifying drug targets in cancer metastasis 01-Apr-2022 07:00 RNS
Rapid information on patient response to therapies 29-Mar-2022 07:00 RNS
Identifying therapeutic targets in TNBC patients 25-Mar-2022 07:00 RNS
Update on laboratory accreditation 15-Mar-2022 07:00 RNS
Second Price Monitoring Extn 09-Mar-2022 16:41 RNS
Price Monitoring Extension 09-Mar-2022 16:36 RNS
Holding(s) in Company 02-Mar-2022 18:29 RNS
Issue of Equity 18-Feb-2022 17:13 RNS
Potential in immunotherapy treatment selection 21-Jan-2022 07:00 RNS
Concordance of Parsortix with tissue biopsy 17-Jan-2022 07:00 RNS
Update on lab accreditation and ovarian study 13-Jan-2022 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Angle Market Data

Currency UK Pounds
Share Price 8.25p
Change Today -0.45p
% Change -5.17 %
52 Week High 31.35
52 Week Low 8.11
Volume 1,956,110
Shares Issued 322.64m
Market Cap £26.62m
Beta 0.20
RiskGrade 312

Angle Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.5% below the market average29.5% below the market average29.5% below the market average29.5% below the market average29.5% below the market average
28.89% above the sector average28.89% above the sector average28.89% above the sector average28.89% above the sector average28.89% above the sector average
Price Trend
84.98% below the market average84.98% below the market average84.98% below the market average84.98% below the market average84.98% below the market average
85.42% below the sector average85.42% below the sector average85.42% below the sector average85.42% below the sector average85.42% below the sector average
Income Not Available
Growth
55.03% above the market average55.03% above the market average55.03% above the market average55.03% above the market average55.03% above the market average
50.54% above the sector average50.54% above the sector average50.54% above the sector average50.54% above the sector average50.54% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Angle Dividends

No dividends found

Trades for 27-Sep-2024

Time Volume / Share Price
16:24 12,029 @ 8.21p
16:22 30,000 @ 8.11p
16:18 24,347 @ 8.22p
16:17 12,109 @ 8.23p
16:14 25,218 @ 8.12p

Angle Key Personnel

CEO Andrew D Newland
Finance Director Ian F Griffiths
Chair Jan Groen

Top of Page